EGFR and ovarian cancer: Linear regression analysis of our Proseek® data had found six of these proteins to have a statistically significantly trend (p < 0.001); CA125, CXCL13, CD40L, CD69, and LAP.TGF-β1 levels were higher in ovarian cancer serum samples, while EGFR levels were lower.